Sign Up Today and Learn More About Curie.Bio Stock
Invest in or calculate the value of your shares in Curie.Bio or other pre-IPO companies through EquityZen's platform.
Curie.Bio Stock (CUIB)
Curie.Bio is a founder-focused seed-stage venture capital firm.
About Curie.Bio Stock
Founded
2022
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Curie.Bio Press Mentions
Stay in the know about the latest news on Curie.Bio
Kidney biotech R1's $78m debut, and other biofinancings
pharmaphorum • Mar 21, 2026
R1 launches with $77.5m for chronic kidney disease drug
longevity • Mar 20, 2026
美国肾病创新药研发商R1 Therapeutics获得7750万美元A轮融资
ifastdata • Mar 20, 2026
R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia
pharmaceutical-technology • Mar 19, 2026
R1 Therapeutics launches with $77.5M Series A to advance first-in-class kidney disease treatment AP306
techstartups • Mar 18, 2026
Curie.Bio Management
Leadership team at Curie.Bio
CSO Partner
Chris De Savi
Co-Founder & Chairman
Alexis Borisy
Join now and verify your accreditation status to gain access to:
- Curie.Bio Current Valuation
- Curie.Bio Stock Price
- Curie.Bio Management
- Available deals in Curie.Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Curie.Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Curie.Bio Revenue and Financials
- Curie.Bio Highlights
- Curie.Bio Business Model
- Curie.Bio Risk Factors
- Curie.Bio Research Report from SACRA Research
Trading Curie.Bio Stock
How to invest in Curie.Bio stock?
Accredited investors can buy pre-IPO stock in companies like Curie.Bio through EquityZen funds. These investments are made available by existing Curie.Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Curie.Bio stock?
Shareholders can sell their Curie.Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
